anti-aging

Devices & Diagnostics, BioPharma, Artificial Intelligence

Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion

Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.

How could a Powerball lottery winner transform healthcare?

Wednesday’s $564 million Powerball drawing (which has a $381 million cash value) left winners in North Carolina, Texas and Puerto Rico just slightly richer. It’s easy to fantasize about how you’d spend that kind of money, where you’d invest it, what you would buy. That kind of money could make huge strides in areas of healthcare, […]

Anti-aging drugs could be in the works

As people get older, they are are more at risk for the major causes of death, like heart disease, stroke, certain cancers, and Alzheimer’s. But some researchers are looking at ways to take the age factor out of the picture, at least a little bit. A new study, according to IFLScience, is looking at a […]